Symposium C4
Responsible Supply Chains to Assure Global Health

Wednesday 24 May 2017
Stockholmsmässan : K11


Access to medicines in many countries, especially for the poor and underprivileged, remains less than optimal. FIP is committed to identify barriers limiting adequate supply and availability of essential medicines for patients and jointly work with governments and local professional organization to strive for improved access to safe and effective medicines for their populations. This session aims to raise awareness among the pharmaceutical sciences community how fragile medicine supply chains across the globe can be. In addition, experts will debate the impact of pharmaceutical development on the environment and how this may factor into the social responsibility of enhancing access to medicines.

Chair: Takuya Kumamoto, Musashino University, Japan


09:00 – 09:35 Environmental impact of drug manufacturing
Takuya Kumamoto, Musashino University, Japan

09:35 – 10:10 Pharmaceuticals in surface and ground water: Case in Nigeria
Olatunde James Olaitan, Olabisi Onabanjo University, Nigeria

10:10 – 10:30 BREAK

10:30 – 11:05 Resilience and robustness of pharma supply chains
David Gonsalvez, Malaysia Institute for Supply Chain Innovation (MISI), Malaysia

11:05 – 11:40 Bioeconomy - How to build human resource capacity in scientific research
Ahmed Fahmi, UNESCO, France

11:40 – 12:00 Panel discussion
Takuya Kumamoto, Musashino University, Japan